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cannot be changed in any way or used commercially.Background: Endothelial dysfunction, manifesting as
attenuated flow-mediated dilation (FMD), is clinically
important. Antioxidants may prevent this dysfunction;
however, the acute effects of oral administration in humans
are unknown. Low flow-mediated constriction (L-FMC), a
further parameter of endothelial health, is largely unstudied
and the mechanisms for this response unclear.
Methods: Twelve healthy participants (five women and
seven men) completed three test conditions: control;
antioxidant cocktail (a-lipoic acid, vitamins C and E); and
prostaglandin inhibitor ingestion (ibuprofen). Ultrasound
measurements of brachial artery responses were assessed
throughout 5min of forearm ischemia and 3min after.
Subsequently, an ischemia–reperfusion injury was induced
by a 20-min upper arm occlusion. Further, vascular
function protocols were completed at 15, 30,
and 45min of recovery.
Results: Endothelial dysfunction was evident in all
conditions. FMD was attenuated at 15min after ischemia–
reperfusion injury (Pre: 6.240.58%; Post15:
0.240.75%; mean SD, P<0.05), but recovered by
45min. Antioxidant administration did not preserve
FMD compared with control (P> 0.05). The magnitude
of L-FMC was augmented at 15min (Pre: 1.44 0.27%;
Post15: 3.751.73%; P<0.05) and recovered
by 45min. Ibuprofen administration produced the largest
constrictive response (Pre: 1.131.71%; Post15:
5.573.82%; time condition interaction: P<0.05).
Conclusion: Results demonstrate ischemia–reperfusion
injury causes endothelial dysfunction and acute oral
antioxidant supplementation fails to reduce its magnitude.
Our results also suggest that a lack of shear stress during
occlusion combined with suppression of prostaglandin
synthesis magnifies L-FMC, possibly due to augmented
endothelin-1 expression.
Keywords: allometric scaling, antioxidants, flow-mediated
dilation, ibuprofen, low flow-mediated constriction, shear
rate
Abbreviations: COX, cyclooxygenase; ET-1, endothelin-1;
FMD, flow-mediated dilation; L-FMC, low flow-mediated
constriction; MBV, mean blood velocity; PGE2,
prostaglandin E2; PGI2, prostacyclin; ROS, reactive oxygen
species; TVR, total vascular reactivityCopyright © Lippincott Williams & Wilkins. Unauth
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ndothelial dysfunction, the impaired ability for
vascular dilation due to decreased production or
bioavailability of nitric oxide [1], can result from
ischemia–reperfusion injury, a period of occlusion to a
vascular bed followed by the rapid reintroduction of blood
flow to this area [2,3]. Ischemia–reperfusion attenuates
vasodilation via the production of reactive oxygen species
(ROS) during the initial minutes of reperfusion [4]. This
process is mediated by the production of superoxide [5],
potential sources of which include the mitochondrial elec-
tron transport chain [6] and NADPH oxidase [4]. Superoxide
in turn reacts with nitric oxide to form peroxynitrite, a
highly reactive oxidant [5]. Hence, reducing superoxide
production would attenuate the endothelial dysfunction
caused by ischemia–reperfusion injury. Noninvasive
assessment of endothelial function using repeated flow-
mediated dilation (FMD) protocols, combined with an
induced ischemia–reperfusion injury has been used to
assess interventions to attenuate this dysfunction [7–10].
Antioxidants’ preventive role in ischemia–reperfusion
injury has been suggested due to their ability to scavenge
ROS [3,5,11]. Acute intra-arterial infusion of vitamin C
decreases endothelial dysfunction in healthy individuals
and peripheral artery disease patients [11] and attenuates
the reduction in FMD following ischemia–reperfusion
injury induced by exercise in patients with intermittent
claudication [10]. However, vitamin C’s interaction with
superoxide can likely only occur at supraphysiological
concentrations [12,13] and in contrast, oral supplement-
ation at reduced dosages has failed to attenuate endothelialorized reproduction of this article is prohibited.
DOI:10.1097/HJH.0000000000000033
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Carter et al.dysfunction [14]. However, this noneffect of oral supple-
mentation was determined longitudinally and acute
responses were not assessed. Moreover, administration
of an antioxidant cocktail reduced several key indicators
of ischemia–reperfusion injury, but not vascular constric-
tion [3,5]. Critically, in these studies, the magnitude of
ischemia (2.5 h) exceeds greatly than that during typical
FMD measures, which may influence results [15]; further-
more, protocols tested an animal model as opposed to
humans. Thus, the acute effect of oral antioxidant admin-
istration in humans has not been studied, and combining
antioxidants could perhaps provide a higher level of pro-
tection from ischemia–reperfusion injury than vitamin C
in isolation.
Recently, studies of prolonged low flow have shown that
endothelial dysfunction may also manifest as enhanced
vasoconstriction [16–18]. This low flow-mediated constric-
tion (L-FMC) is nitric oxide independent and provides a
measure of resting vasomotor tone [16], which can comp-
lement FMD as a measure of endothelial health [19]. The
magnitude of L-FMC is suggested to be mediated in part by
prostaglandin, endothelial hyperpolarizing factor [16], and
endothelin-1 (ET-1) [20] availability. During occlusion, it is
suggested these pathways may be altered due to increased
retrograde flow and subsequent production of ROS by
NADPH oxidase [18].
Limited research has studied interventions to manipulate
L-FMC compared with FMD, which is surprising consider-
ing the reported clinical importance of this measure [19,21].
Attenuation of L-FMC was achieved via prostaglandin
blockade [16]; however, measurements occurred in the
radial not the brachial artery, which is typically used for
assessments of endothelial function using FMD [15]. Thus,
mechanistic information regarding L-FMC in the brachial
artery would allow a greater understanding of the role of
this parameter in endothelial responses to ischemia–
reperfusion injury.
One difficult aspect regarding the interpretation of
ischemia–reperfusion studies involves the consistent
and inevitable alteration of the diameter of the artery
studied. In particular, recent studies by van den
Munckhof et al. [22] have shown that upper arm occlusion
for periods of 20min results in a prolonged dilation that
alters baseline diameter. Since recent work by Atkinson
et al. [23,24] has shown the importance of controlling for
basal diameter using data from seminal studies, the work
in this study was assessed using both data analysis tech-
niques.
Therefore, the aims of this study were to assess inter-
ventions that impact FMD and L-FMC in the brachial artery
throughout an ischemia–reperfusion injury protocol and
also look at a data analysis comparison by using baseline
diameter as a covariate as suggested by Atkinson et al.
[23,24]. Specifically we aimed to determine the efficacy of
acute administration of an oral antioxidant cocktail on the
preservation of FMD following ischemia–reperfusion injury
and the impact of prostaglandin inhibition on the magni-
tude of L-FMC. It was hypothesized that following ische-
mia–reperfusion injury, oral supplementation of an
antioxidant cocktail would attenuate the reduction in
FMD, and that prostaglandin blockade via ibuprofenCopyright © Lippincott Williams & Wilkins. Unaut
340 www.jhypertension.comadministration would abolish the enhanced L-FMC that
occurs. We also hypothesized that an alternative interpret-
ation may arise from the inclusion of baseline diameters
as covariates with regard to the alterations of vascular
function induced by ischemia–reperfusion and the two
intervention strategies.
METHODS
Participants
Twelve healthy participants (five women and seven
men; mean SD, age: 26.2 6.7 years, body mass:
66.5 16.7 kg, height: 168.2 12.7m) volunteered for the
study. Participants were screened prior to testing and
exclusion criteria included smoking, pregnancy, current
medication, and presence of apparent cardiovascular or
metabolic disease. Women were assessed in a standardized
phase (days 1–7) of the menstrual cycle according to
recommended guidelines [25].Study design and procedures
Participants attended the temperature-controlled (20–228C)
laboratory at the same time of day on three separate
occasions (control, antioxidant, and ibuprofen trials), follow-
ing an overnight fast and abstinence from caffeine. Partici-
pants were also instructed to avoid strenuous exercise for
24 h. The initial test acted as a control trial. Prior to
subsequent visits, participants randomly ingested either
an antioxidant cocktail [300mg a-lipoic acid, 500mg vita-
min C, and 200 IU vitamin E (water dispersible)] 2 h prior
and a further cocktail [300mg a-lipoic acid, 500mg vita-
min C, and 400 IU vitamin E (water dispersible)] 1.5 h prior
[26]; or 1200mg of a prostaglandin inhibitor (ibuprofen)
1 h prior.
On each occasion participants arrived, were instru-
mented, and rested supine for 20min. Endothelial function
was subsequently assessed using noninvasive vascular
function protocols for the assessment of FMD and L-FMC
of the right brachial artery, of which four were performed
during each trial. The first vascular function protocol (Pre)
was followed by a 10-min recovery period. After this
period, an ischemia–reperfusion injury was induced by a
20-min occlusion with a cuff positioned around the upper
right arm, and pressure maintained at 220mmHg. Follow-
ing cuff deflation, a further three vascular function proto-
cols were carried out at 15, 30, and 45min of recovery.
Blood pressure was continually monitored throughout test-
ing at the left radial artery via arterial tonometry (model
Colin CBM-7000; Colin Medical Instruments, San Antonio,
Texas, USA) and heart rate measured via a three-lead
electrocardiograph. Signals were acquired via a data acqui-
sition system (PL3008 PowerLab 8/30; ADInstruments,
Colorado Springs, Colorado, USA) and software (LabChart
7, ADInstruments).Vascular endothelial function testing
procedures
Noninvasive assessment of brachial artery vascular function
was carried out using automated edge detection for
diameter analysis in real time and fast Fourier transformhorized reproduction of this article is prohibited.
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Arterial blood flow and shear rates were assessed using a
linear array 10 Mhz Doppler ultrasound probe in triplex
mode (Prosound Alpha 6; Hitachi Aloka Medical, Tokyo,
Japan). The FMD protocol was performed according
to published guidelines [15,25] using M-mode imaging.
M-mode imaging enables a theoretical spatial resolution
of less than 0.001mm and high temporal resolution
(200Hz). This high spatial and time resolution also enabled
b-stiffness index to be determined prior to each vascular
function measurement. The position of the probe was
marked using indelible ink and maintained using a probe
holder to ensure stable, consistent measurements and,
at each testing session, previous baseline images were
used to ensure the same portion of the vessel was
assessed. A blood pressure cuff was placed around the
forearm distal to the probe with the proximal border
adjacent to the medial epicondyle, as recommended to
assess endothelial-dependent nitric oxide dilation [15].
Arterial diameters were obtained for 30 s at baseline
and throughout the 5-min occlusion period. Postcuff
deflation, the vessel was imaged for a further 3.5min.
Throughout this period, blood flow was also acquired.
This procedure was repeated for each vascular function
measure (Pre, Post15, 30, and 45).
Data analysis traditional methods
Basal arterial diameter was determined as the average of
30 heart cycles prior to cuff inflation. Peak vessel dilation
was calculated from the highest average diameter of three
consecutive heart cycles after cuff deflation, whereas occlu-
sion diameter was determined as the average of 30 heart
cycles prior to cuff deflation. From this data, FMD and
L-FMC were calculated as previously described [27]. Total
vascular reactivity (TVR) was determined as the sum of the
absolute L-FMC and absolute FMD.
Basal MBV was determined for 30 s prior to the 5-min
forearm occlusion, whereas occlusive MBV determined for
30 s prior to cuff deflation. After cuff release, MBV was
calculated throughout reactive hyperemia for 60 s and the
peakbloodvelocity during this timewasdetermined. Finally,
shear rates were calculated (8MBV/arterial diameter at the
measurement time) at these same time points.
Data analysis using covariate analyses
incorporating basal diameters
Atkinson et al. [23] recently described an allometric-based
approach to adjust relative FMD to take into account basal
diameter of the brachial artery. With the possibility that
basal diameter is altered within the current study design,
this method involves including basal diameter as a covariate
at each time point.
Statistical methods traditional approach
All data are presented as mean standard deviation
(SD). Data were assessed for normal distribution using
Kolmogorov–Smirnov test. Absolute and relative FMD,
relative L-FMC, TVR, peak blood velocity and shear rate,
time to peak dilation, and basal and occlusive shear
rates, mean arterial pressure, heart rate, b-stiffness index,Copyright © Lippincott Williams & Wilkins. Unauth
Journal of Hypertensionand MBV were analyzed by two way-repeated measures
analysis of variance (ANOVA) with ‘condition’ and ‘time’
treated as within subject variables and a priori comparisons
made between Pre and all other time points while the
control condition was compared to ibuprofen or anti-
oxidant trials. Data were analyzed using statistical software
(SPSS Version 18.0; IBM Corporation, Somers, New York,
USA), with significance accepted as P 0.05.
Statistical methods analysis of covariance-
based allometric approach
A separate analysis was complete using an allometric
approach that controls for changes in basal diameter. To
do this, basal, maximum, and occlusion diameters were log
transformed and absolute dilation, absolute constriction,
and total range of the log transformed data were calculated.
The slope of the regression between basal diameter
and maximal diameter was calculated as 0.98 and the
95% confidence interval was less than 1, suggesting that
maximal diameter does not increase proportionally with a
change in basal diameter. This agrees with previous work
by Atkinson et al. [24] and suggests that controlling for basal
diameter is an appropriate procedure.
To analyze our FMD, L-FMC, and TVR more appropri-
ately, log-scaled values of ‘dilation’, ‘constriction’, and ‘total
range’ were entered into a mixed model linear analysis
of covariance (ANCOVA) with ‘condition’ and ‘time’ as
repeated factors, ‘basal diameter’ as a covariate, and
‘dilation’, ‘constriction’, and ‘total range’ as dependent
factors in separate analyses. Covariate-adjusted means were
calculated and then back-transformed. To provide values
that one would typically interpret as relative dilation, con-
striction and total range, adjusted changes in diameter
values were calculated by subtracting 1 and then multiply-
ing by 100 according to Atkinson et al. [24]. The ‘corrected’
dilation, constriction, and range were then interpreted and
compared to the traditional approach.
The day-to-day repeatability (coefficient of variation) for
FMD, L-FMC, and TVR is 15, 20, and 12%, respectively in this
laboratory. The absolute day-to-day difference is 1.1, 1.4,
and 1.7%, respectively. Power calculation based on
previous work [27] suggested a sample size of 10 partici-
pants would be required to see a 1% change in FMD or L-
FMCwith a standard deviation of 2.8%, a probability of 0.05,
and a b of 0.80. Thus, adequate statistical power was aided
by using a sample of 12 in repeated methods within subject
study design.
Ethics statement
The experimental procedures and potential risks were
explained to participants prior to testing and written
informed consent obtained. The University of Essex ethics
committee approved the experimental protocol, which
conformed to the Declaration of Helsinki.
RESULTS
Hemodynamic responses to antioxidant,
ibuprofen, and ischemia
Heart rate and mean arterial pressures were not affected
by either the administration of the antioxidant cocktail ororized reproduction of this article is prohibited.
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TABLE 1. Hemodynamic parameters under each condition and at each vascular function assessment
Control Ibuprofen Antioxidant
Pre Post15 Post30 Post45 Pre Post15 Post30 Post45 Pre Post15 Post30 Post45
HR (bpm) 5913a 5611 5610 559 5713a 538 559 539 5912a 5511 5410 5612
MAP (mmHg) 7910 8512 8310 8311 799 8510 808 808 8210 8110 8011 8310
b-Stiffness index 112 102 102 103 112 122 113 112 113 104 114 124
HR, heart rate; MAP, mean arterial pressure.
aDenotes a significant main effect for time (P<0.05) with Pre values significantly different from other time points within each condition.
Carter et al.ibuprofen (P> 0.05, Table 1). In addition, the ischemia–
reperfusion procedure did not alter mean arterial press-
ures (P> 0.05, Table 1). There was a reduction in heart
rate that was similar under all conditions of approximately
3–4 bpm over the course of the 2.5-h protocol (P¼ 0.04,
Table 1). Indirect measures of vascular tone derived from
brachial b-stiffness index (ultrasound imaging and pulse
pressure measures) showed no effect of time (P> 0.05,
Table 1) or condition (P> 0.05, Table 1), suggesting that
the protocol and manipulations did not alter vascular
tone.
Flow-mediated dilation and oral antioxidant or
ibuprofen administration
Reduced FMD was evident in all three conditions following
20min of forearm occlusion using the traditional statisticalCopyright © Lippincott Williams & Wilkins. Unaut
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FIGURE 1 (a) Absolute flow-mediated dilation (FMD) and (b) relative FMD before (Pr
ibuprofen, and antioxidant conditions. Indicates a significant difference (P<0.05) from
342 www.jhypertension.comapproach. At 15-min after ischemia–reperfusion injury,
absolute FMD (Fig. 1a) and relative FMD (Fig. 1b) were
reduced compared with baseline values with similar
reductions under all conditions (P> 0.05). Antioxidant
administration did not preserve FMD compared with con-
trol (P> 0.05). Moreover, the pattern of recovery was not
affected by either intervention (P> 0.05), with the magni-
tude of the attenuation of FMD reducing at 30 and 45min.
Basal diameters were larger at 15min after ischemia–reper-
fusion compared with the before ischemia–reperfusion,
but returned to similar values at the 30 and 45min time
points (Fig. 2a, b, P> 0.05). However, no differences were
evident between conditions at any time point of assessment
(Fig. 2 a, b, P> 0.05). Occlusive arterial diameters during
each vascular function test replicated this response
(Fig. 2c). Finally, the time to peak vessel dilation was nothorized reproduction of this article is prohibited.
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e) and following a 20-min ischemia–reperfusion injury (shaded area) for control,
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FIGURE 2 (a) Thirty second average maximum and (b) minimum brachial artery diameters in the basal state before each vascular function test, and (c) 30 s average
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ibuprofen, and antioxidant conditions. Indicates a significant difference (P<0.05) from Pre (main effect for Time) determined by post-hoc analysis.
Vascular injury, ibuprofen, antioxidantsinfluenced by condition (P> 0.05) nor the time of assess-
ment (P> 0.05).
Analyzing the FMD responses using basal diameter as a
covariate did not alter the results. Endothelial dysfunction
was still evident following the ischemia–reperfusion injury
(main effect for time, P< 0.01, Fig. 3a) and followed a
similar pattern compared with the traditional statistical
approach.Copyright © Lippincott Williams & Wilkins. Unauth
Journal of HypertensionLow flow-mediated constriction and
antioxidant or ibuprofen administration
L-FMC demonstrated a similar time course of response
to ischemia–reperfusion injury as noted with FMD for all
conditions (Fig. 4). The magnitude of L-FMC was signifi-
cantly greater 15min after occlusion compared with
basal values (Fig. 4, P< 0.05) and at 45min, this had
recovered to values similar to that at baseline (P> 0.05).orized reproduction of this article is prohibited.
www.jhypertension.com 343
12
*
*
9
6
3
F
M
D
 r
el
at
iv
e 
(%
)
L
o
w
 fl
o
w
 m
ed
ia
te
d
co
n
st
ri
ct
io
n
 (
%
)
T
o
ta
l v
as
cu
la
r 
re
ac
ti
vi
ty
 (
%
)
0
–3
–6
2
0
–2
–4
–6
–8
–10
12
10
8
6
4
2
0
Pre 15 post 30 post 45 post
Pre 15 post 30 post
Interaction for time x condition
P = 0.06
45 post
Pre 15 post 30 post 45 post
Control
Ibuprofen
Antioxidants
(a)
(b)
(c)
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difference (P<0.05) from Pre (main effect for time) determined by post-hoc analysis. Only a trend (P¼0.06) was apparent regarding the time condition interaction
regarding L-FMC.
Carter et al.L-FMC did not differ significantly between conditions
(P> 0.05); however, ibuprofen administration resulted
in the largest constrictive response, with approximately
four-fold increase between before and 15min after
ischemia–reperfusion injury (Fig. 4, P< 0.05), compared
with a 1.3-fold and almost no change under controlCopyright © Lippincott Williams & Wilkins. Unaut
344 www.jhypertension.comand antioxidant conditions, respectively from before to
15min after ischemia–reperfusion injury. No significant
interactions were apparent under control or antioxidant
conditions (P> 0.05).
Using basal diameter as a covariate in the analysis of
L-FMC did not alter the results. An increased L-FMC washorized reproduction of this article is prohibited.
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Vascular injury, ibuprofen, antioxidantsstill evident with the greatest effect noted in the ibuprofen
condition (Fig. 3b). However, the interaction only dis-
played a strong trend (P¼ 0.06).Total vascular reactivity and antioxidant or
ibuprofen administration
The total diameter range of the brachial artery during the
vascular function assessment (TVR) was altered by the
ischemia–reperfusion injury and exhibited a reduction
(main effect for time, P< 0.01). Although this was most
apparent in the antioxidant condition, there was no signifi-
cant interaction (P> 0.05, Fig. 3c).
After controlling for basal diameter changes that
occurred after ischemia–reperfusion compared with Pre
values using the basal diameter as a covariate, there were
no noticeable differences in the results compared with
the traditional approach. The largest reduction in total
range occurred at Post15 and this reduction was still evident
at Post30 compared with Pre (P< 0.01, Fig. 3c). There was
no specific effect of either antioxidant or ibuprofen admin-
istration.Blood velocity and shear rates
Ischemia–reperfusion injury altered shear rates and MBVs.
Following ischemia–reperfusion injury, there was a
reduction in peak blood velocity at 15min of recovery
(Fig. 5a), although this did not reach statistical significance
(main effect for time, P¼ 0.08). A return to Pre values was
noted at the 30 and 45min time points (Fig. 5a, P> 0.05).
Peak shear rate following cuff deflation demonstrated this
same pattern of response (Fig. 5b), with a mean reduction
of 27.09 s1 (main effect for time, P< 0.05); however, by
30 and 45min of recovery, these values were similar to
baseline (P> 0.05). There was no effect for condition on
either of these parameters (P> 0.05). Although not stat-
istically significant, there was a trend for a reduction
in occlusive MBV at 15min of recovery compared withCopyright © Lippincott Williams & Wilkins. Unauth
Journal of Hypertensionbaseline (Fig. 6a). Similarly, occlusive shear rate
was depressed following ischemia–reperfusion injury
(Fig. 6b); however, this did not reach statistical significance
(main effect for time, P¼ 0.07). Condition significantly
influenced these occlusive measures, with values signifi-
cantly depressed in the ibuprofen condition compared
with the control and antioxidant conditions (main effect
for condition, P< 0.05). Finally, basal MBV and shear
rates were significantly reduced at all time points following
ischemia–reperfusion injury (Fig. 7a,b, P< 0.05), and
this was not influenced by condition (P> 0.05).
DISCUSSION
In agreement with previous studies [15,25], we demonstrate
that upper arm ischemia–reperfusion injury induces endo-
thelial dysfunction, as evidenced by a significant reduction
in FMD following a 20-min vascular occlusion. Moreover,
the observed augmentation in L-FMC suggests further vas-
cular dysfunction using this approach [16–19]. The inter-
ventions of oral antioxidant and ibuprofen did not decrease
the magnitude of the ischemia–reperfusion injury as origin-
ally hypothesized. In fact, following ischemia–reperfusion
injury, ibuprofen administration augmented L-FMC,
whereas acute oral antioxidant supplementation failed to
preserve FMD. Allometric scaling and using the basal
diameter as a covariate in the analyses based on the work
by Atkinson et al. [23,24] did not influence the results or
alter any conclusions. However, this method should
become standard practice to enable comprehensive com-
parisons between studies.
As such these data suggest some potentially unfavorable
effects of acute ibuprofen administration and discount
the possibility that oral administration of an antioxidant
cocktail containing vitamins C, E, and a-lipoic acid is of
benefit in attenuating the reduction in FMD induced by
ischemia–reperfusion injury, although they may limit the
increased L-FMC.orized reproduction of this article is prohibited.
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Carter et al.Pattern of response following ischemia–
reperfusion injury
The observed alterations in endothelial function following
ischemia–reperfusion injury may relate to previously
described mechanisms of reduced nitric oxide production
or bioavailability [1] due to the production of ROS during
the initial period of reperfusion [8]. Furthermore, following
occlusion, both peak shear rate and MBV were reduced,
possibly indicating microvascular endothelial dysfunction
[18].
The pattern of response following ischemia–reperfusion
injury was similar for both FMD and L-FMC. FMD was
depressed and L-FMC augmented to the greatest extent
at 15min of recovery, with these parameters returning to
Pre ischemia–reperfusion injury levels by 45min. This time
course agrees with previous work [18]; furthermore, the
return to basal diameters confirms that using multiple
vascular function tests is not an explanation for the
enhanced L-FMC observed [18]. Additionally, the patternCopyright © Lippincott Williams & Wilkins. Unaut
346 www.jhypertension.comof response was not influenced by condition, demonstrat-
ing that the interventions assessed do not modify recovery
rates from ischemia–reperfusion injury.
Time to peak dilation has also been shown to have a
similar response pattern following ischemia–reperfusion
injury as that of FMD and L-FMC [18]; however, this was not
evident in this study. One potential confounding factor that
may explain this is the observation that after an ischemia–
reperfusion injury, some individuals display no dilation,
which creates an inappropriate time to peak dilation value.
Furthermore, whether this measure has any significance for
endothelial function is unclear, with similar times to peak
dilation found in healthy and diseased populations [28].
Suppression of prostaglandins magnifies low
flow-mediated constriction
Ibuprofen administration induced a greater vasoconstric-
tive response after ischemia–reperfusion injury compared
with the control or antioxidant conditions. The magnitudehorized reproduction of this article is prohibited.
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FIGURE 6 Occlusive mean blood velocity (a) and shear rates (b) during the last 30 s before cuff deflation measured during the vascular function assessments at Pre and at
15, 30, and 45min after a 20-min ischemia–reperfusion injury (shaded area). Separate lines indicate control, ibuprofen, and antioxidant conditions. Indicates a main effect
for condition (P<0.05) with the ibuprofen condition significantly different from the control and antioxidant conditions.
Vascular injury, ibuprofen, antioxidantsof L-FMC is mediated in part by cyclooxygenase (COX)
activity, endothelial hyperpolarizing factor [16], and ET-1
[20] availability, suggesting that the intervention altered one
of these pathways.
Ibuprofen is a nonselective COX inhibitor, which ulti-
mately leads to a reduction in prostaglandin synthesis.
Prostacyclin (PGI2) and prostaglandin E2 (PGE2) are two
such prostanoids synthesized by vascular endothelial and
smooth muscle cells [29,30] and exert potent vasodilatory
effects. Hence, the inhibition of COX by ibuprofen may
have reduced these vasodilatory prostanoids and limited
their effects, leading to enhanced vasoconstriction. How-
ever, Pre ischemia–reperfusion injury L-FMC in the ibupro-
fen condition was not significantly different from the
control condition, thus making the reduced prostaglandin
synthesis alone unlikely to be the sole cause of the
increased L-FMC observed following ischemia–reperfusion
injury. Furthermore, our results do not agree with Gori et al.
[16] who reported prostaglandin blockade attenuatedCopyright © Lippincott Williams & Wilkins. Unauth
Journal of HypertensionL-FMC; however, their assessment was made in the
radial artery, which may exhibit differential sensitivity to
this prostanoid. Our observations also suggest that the
enhanced vasoconstriction that occurred after ischemia–
reperfusion injury may be related to other pathways
involved in the L-FMC response, namely ET-1.
As mentioned, what is of mechanistic interest is that
ibuprofen administration increased the constrictive
response to occlusion only after the ischemia–reperfusion
injury. This suggests that factors resulting from prolonged
ischemia combined with prostaglandin inhibition lead to
the augmented L-FMC observed. The time course for this
constrictive response agrees with the results of Rakobow-
chuk et al. [18] who suggest that the prolonged retrograde
flow during occlusion stimulates the generation of ROS
from NADPH oxidase, leading to heightened vasoconstric-
tion. It could, therefore, be possible that the combination of
enhanced retrograde flow with prostaglandin blockade
magnified L-FMC. Increases in retrograde flow elevateorized reproduction of this article is prohibited.
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FIGURE 7 Basal mean blood velocity (a) and shear rates (b) at Pre and at 15, 30, and 45min after a 20-min ischemia–reperfusion injury (shaded area). Separate lines
indicate control, ibuprofen, and antioxidant conditions. Indicates a significant difference (P<0.05) from Pre (main effect for time) determined by post-hoc analysis.
Carter et al.expression of ET-1 [31], a potent vasoconstrictor [32]. More-
over, prostaglandins inhibit ET-1 secretion [33]; hence, this
would be abolished with ibuprofen administration, leading
to enhanced bioavailability of this vasoconstrictor and
subsequent vasoconstriction mediated through the ETA
receptor. Alternatively, ET-1 can also induce vasodilation
by acting through ETB receptors, producing COX products
[34,35]. This receptor-mediated relaxation was attenuated
following COX inhibition in rat carotid arteries [35];
hence, a similar response may occur in the brachial artery.
Collectively, the cumulative effects of these mechanisms
could explain the increased L-FMC following ibuprofen
administration.
Reductions in shear stress may explain low
flow-mediated constriction responses
The increased L-FMC observed may have also been a
function of the reduction in shear stress following ische-
mia–reperfusion injury. Basal shear rates (measured beforeCopyright © Lippincott Williams & Wilkins. Unaut
348 www.jhypertension.comeach vascular function test) were reduced at all time points
following ischemia–reperfusion injury, whereas occlusive
shear during the vascular function protocol at 15min into
recovery was also depressed compared with Pre ischemia–
reperfusion injury levels. Shear stress exhibits a dose-
dependent relationship with ET-1 [36], with increased shear
rates suppressing ET-1 expression [37,38]. Consequently,
the reductions in shear stress observed may have aug-
mented ET-1 expression, leading to enhanced vasoconstric-
tion following ischemia–reperfusion injury. Furthermore,
reductions in shear stress provide an additional mechanism
to explain the potentiated L-FMC during the ibuprofen
condition. Occlusive shear rates following ibuprofen
administration were significantly depressed compared with
the control or antioxidant conditions throughout the vas-
cular function assessments and, as previously discussed,
blocking COX and reducing prostaglandin synthesis
removes their inhibitory role for ET-1 secretion, which in
turn may lead to greater ET-1 bioavailability. A possiblehorized reproduction of this article is prohibited.
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Vascular injury, ibuprofen, antioxidantsexplanation is that the absence of shear stress combined
with prostaglandin suppression further augmented the
expression of ET-1 and hence magnified L-FMC.Antioxidants fail to preserve flow-mediated
dilation
Acute oral administration of an antioxidant cocktail was
unable to attenuate endothelial dysfunction as relative FMD
was still impaired after ischemia–reperfusion injury to a
similar magnitude as the control condition, whereas
absolute FMD was marginally decreased. The lack of effect
of supplementation may be explained by the reported
requirement of supraphysiological dosages of vitamin C
in order to scavenge superoxide [12,13]. A vitamin C con-
centration of 10–100mmol/l has been theorized to effec-
tively achieve this [13], and based on previous work using
the same supplementation protocol [26], plasma concen-
trations would not have reached this concentration. Results,
thus, demonstrate that, as has been previously found using
chronic supplementation of vitamin C [14,39,40], oral
administration is unable to attenuate endothelial dysfunc-
tion in an acute setting.
Although an antioxidant cocktail was administered as
opposed to an isolated vitamin, this did not enhance the
antioxidants’ efficacy to preserve FMD. Longitudinal oral
administration of vitamin E has attenuated endothelial
dysfunction in some clinical populations [41–44], and com-
bined with vitamin C may have enhanced the antioxidant
effects of the intervention. However, as found in animal
models [3,5], the magnitude of dysfunction was unaffected.Study limitations
The study design featured multiple laboratory visits; more-
over, the use of both forearm and upper arm cuff positions
(for the assessment of FMD and to induce an ischemia–
reperfusion injury, respectively) required repositioning of
the probe within testing sessions. It is possible a different
part of the brachial artery may have, therefore, been imaged
at each test visit and during testing; however, previous
baseline images were used to reduce this occurrence com-
bined with indelible ink to ensure correct probe replace-
ment. Furthermore, there were no significant differences
between baseline artery diameters between conditions at
any time points throughout the vascular function measures,
indicating that the same vessel segment was assessed each
time. As well any alterations in basal diameters were used as
a covariate in the allometric scaling analyses and this did not
alter the findings. Finally, brachial artery b-stiffness index
and mean arterial pressure were similar at all vascular
function measurements, further supporting the idea that
the portion of the vessel that was assessed had similar
structural properties and was under similar magnitudes
of tension.
In conclusion, this study demonstrates that endothelial
dysfunction following ischemia–reperfusion injury can
present as both attenuated FMD and increased L-FMC.
The use of an acute oral antioxidant supplementation
fails to prevent the resultant reduction of FMD and
confirms that the requirement of supraphysiological
dosages, and the subsequent reaction rates with nitricCopyright © Lippincott Williams & Wilkins. Unauth
Journal of Hypertensionoxide and superoxide, limit the effectiveness of this
as a treatment option. Enhanced L-FMC following
ibuprofen supplementation suggests that reduced levels
of prostaglandins combined with prolonged retrograde
flow and a lack of shear stress during ischemic occlusion
lead to this heightened vasoconstriction. This may be
due to increased expression of ET-1 as prostaglandin’s
habitual suppression of this vasoconstrictor is abolished.
Conversely, antioxidants may impact the L-FMC response
to ischemia–reperfusion injury and further studies
that assess this are required. Further research is also
necessary to determine the mechanisms involved
in more detail to enable a more comprehensive under-
standing of endothelial responses to ischemia–
reperfusion injury.
Clinical perspectives
Ischemia–reperfusion injury is commonplace in many
clinical situations including acute coronary syndromes,
exacerbation of peripheral vascular disease, and during
organ transplantation procedures. As such, understanding
the roles of commonly used over-the-counter products in
the responses to these injuries is important in the proper
assessment of treatment methods. Here we have shown
that acute administration of an antioxidant cocktail con-
taining vitamins C, E, and a-lipoic acid failed to reduce
the severity of the endothelial dysfunction that occurs
following an ischemia–reperfusion injury. In addition,
our findings suggest detrimental effects of ibuprofen
administration on endothelial function through potenti-
ated vascular vasoconstriction. The potential negative
impact of NSAIDs has been well reviewed [45]. It is evident
that those with a high risk or a definitive diagnosis
of ischemic cardiovascular disease should refrain from
the use of NSAIDs due to their potential to increase the
risk of an ischemic event [46]. The results of this study
present a possible mechanism that may contribute to the
detrimental effects of ibuprofen in the setting of ischemic
disease.
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Reviewer 1
Strength of the study: This study addresses an interesting
subject as to the potential mechanisms involved in posti-
schemic reperfusion, as reflected by a reduced flow-medi-
ated brachial artery vasodilatation which was accentuated
in the presence of prostaglandin inhibition. The interesting
part is that supraphysiological doses of an antioxidant
cocktail did not have an effect on ischemia-induced
reduction in forearm blood flow. Although the antioxidant
cocktail was given at supraphysiological doses, it is not
known whether their concentrations were sufficient at the
site of their target. Nonetheless, these results may lead to
further exploration of the vascular effects of antioxidants.
Weakness of the study: One of the difficulties is to
understand and follow the way the study was performed
whichmakes it difficult to assess the results. One question is
whether the number of study participants was large enoughin particular for the antioxidant part of the study, since the
standard deviations for this part of the results are relatively
large and larger than for the other parts of the study.Reviewer 2
This study investigates the effect of exogenous antioxidants
and prostaglandin inhibitors on vascular reactivity using
measurement of forearm diameter changes following
ischemic reperfusion. Findings suggest a lack of effect of
oral antioxidant ingestion on flow mediated dilation and
an amplification of the low-flow mediated constriction
due to prostaglandin suppression. Although the multiple
diameter measurements at different times present a signifi-
cant experimental limitation, functional stiffness measure-
ments provide robust support for experimental findings.
The low flow constrictor effects following ischemic reper-
fusion injury present enhanced methods of quantification
of endothelial dysfunction.orized reproduction of this article is prohibited.
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